Composition comprising torasemide and baclofen for treating neurological disorders
US9931326B2 · kind B2 · utility
5Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2014 |
| Grant date | Apr 3, 2018 |
| Priority date | — |
| Expiry date | Sep 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid β toxicity. More specifically, the present invention relates to novel combinatorial therapies of multiple sclerosis, Alzheimer's disease, Alzheimer's disease-related disorders, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.